CHAPTER 1. INTRODUCTION
1.1. Market Definition
1.2. Executive Summary
1.3. The Scope of the Study
CHAPTER 2. RESEARCH METHODOLOGY
2.1. Secondary Research
2.2. Primary Research
2.3. Analytic Tools and Model
2.4. Economic Indicator
2.4.1 Base Year, Base Currency, Forecasting Period
2.5. Expert Validation
2.6. Study Timeline
CHAPTER 3. MARKET ANALYSIS
3.1. Industry Value Chain Analysis
3.2. Porter's Five Force Analysis
3.2.1. Bargaining Power of Buyers
3.2.2. Bargaining Power of Suppliers
3.2.3. Threats of Substitutes
3.2.4. Threats of New Entrants
3.2.5. Degree of Competition
3.3. PESTLE Analysis
3.3.1. Political
3.3.2. Economical
3.3.3. Social
3.3.4. Technological
3.3.5. Legal
3.3.6. Environmental
3.4. SWOT Analysis
3.4.1. Strengths
3.4.2. Weakness
3.4.3. Opportunities
3.4.4. Threats
3.5. Y-O-Y Analysis
CHAPTER 4. MARKET DYNAMICS
4.1. Market Drivers & Opportunities
4.1.1. Changing lifestyles and increasing geriatric population
4.1.2. Growing preference for minimally invasive procedures
4.1.3. Rising prevalence of gastrointestinal cancers and other digestive diseases
4.1.4. Development of biodegradable and drug-eluting gastrointestinal stents
4.1.5. Emerging markets
4.2. Market Restraints & Challenges
4.2.1. Complications associated with gastrointestinal stent implementation
4.2.2. Delays in diagnosis with gastrointestinal stent implementation
CHAPTER 5. GLOBAL GASTROINTESTINAL /GI STENT MARKET – BY
PRODUCT
5.1. Colonic Stents
5.2. Duodenal Stents
5.3. Pancreatic Stents
5.4. Oesophagal Stents
5.5. Biliary Stents
5.6. Others
CHAPTER 6. GLOBAL GASTROINTESTINAL /GI STENT MARKET – BY
MATERIAL
6.1. Plastic Stents
6.2. Self-Expanding Metal Stents
6.2.1. Stainless Steel Stents
6.2.2. Nitinol Stents
6.2.3. Others
CHAPTER 7. GLOBAL GASTROINTESTINAL /GI STENT MARKET – BY
DISEASES TYPE
7.1. Inflammatory Bowel Diseases
7.2. Biliary Diseases
7.3. Gastrointestinal Cancer
7.3.1. Pancreatic Cancer
7.3.2. Oesophagal Cancer
7.3.3. Colorectal Cancer
7.3.4. Stomach Cancer
CHAPTER 8. GLOBAL GASTROINTESTINAL /GI STENT MARKET – BY END
USER
8.1. Ambulatory Surgery Centers
8.2. Hospitals
8.3. Others
CHAPTER 9. GLOBAL GASTROINTESTINAL /GI STENT MARKET - BY
GEOGRAPHY
9.1. Introduction
9.2. North America
9.2.1. U.S.
9.2.2. Canada
9.2.3. Mexico
9.2.4. Costa Rica
9.3. South America
9.3.1. Brazil
9.3.2. Argentina
9.3.3. Chile
9.3.4. Columbia
9.3.5. Others
9.4. Europe
9.4.1. U.K.
9.4.2. Germany
9.4.3. France
9.4.4. Italy
9.4.5. Spain
9.4.6. Russia
9.4.7. Netherlands
9.4.8. Switzerland
9.4.9. Poland
9.4.10. Others
9.5. APAC
9.5.1. China
9.5.2. Japan
9.5.3. India
9.5.4. South Korea
9.5.5. Australia & New Zealand
9.5.6. Malaysia
9.5.7. Singapore
9.5.8. Others
9.6. Middle East & Africa
9.6.1. UAE
9.6.2. Saudi Arabia
9.6.3. Iran
9.6.4. Iraq
9.6.5. Qatar
9.6.6. South Africa
9.6.7. Algeria
9.6.8. Morocco
9.6.9. Nigeria
9.6.10. Egypt
9.6.11. Others
CHAPTER 10. GLOBAL GASTROINTESTINAL /GI STENT MARKET - COMPANY .
PROFILES
10.1. Olympus Corporation
10.2. C.R. Bard, Inc.
10.3. Becton, Dickinson and Company
10.4. Cook Group, Inc.
10.5. Taewoong Medical Co., Ltd.
10.6. Boston Scientific Corporation
10.7. Nanjing Medical Co., Ltd.
10.8. Ella–CS, S.R.O.
10.9. Merit Medical Systems, Inc.
10.10. Conmed Corporation
10.11. Cantel Medical Corporation
10.12. M.I. Tech Co., Ltd.
10.13. Diagmed Healthcare, Ltd.
10.14. Endo-Flex GmbH EN
CHAPTER 11. GLOBAL GASTROINTESTINAL /GI STENT MARKET –
COMPETITIVE LANDSCAPE
11.1. Market Share Analysis
11.2. Strategies adopted by top companies
11.3. Mergers, Acquisitions, Collaborations & Agreements
CHAPTER 12. MARKET INSIGHTS
12.1. Industry Experts Insights
12.2. Analysts Opinions
12.3. Investment Opportunities
CHAPTER 13. APPENDIX
13.1. List of Tables
13.2. List of Figures
